Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

ClinicalTrials.gov ID: NCT05472038

Public ClinicalTrials.gov record NCT05472038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN INTERVENTIONAL, RANDOMIZED, ACTIVE-CONTROLLED, PHASE 1/2/3 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BNT162b RNA-BASED VACCINE CANDIDATES IN COVID-19 VACCINE-EXPERIENCED HEALTHY INDIVIDUALS

Study identification

NCT ID
NCT05472038
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
BioNTech SE
Industry
Enrollment
1,453 participants

Conditions and interventions

Interventions

  • BNT162b2 Bivalent (WT/OMI BA.1) Biological
  • BNT162b2 Bivalent (WT/OMI BA.4/BA.5) Biological
  • BNT162b5 Bivalent (Original/OMI BA.4/BA.5) Biological
  • BNT162b5 Bivalent (WT/OMI BA.2) Biological
  • BNT162b6 Bivalent (Original/OMI BA.4/BA.5) Biological
  • BNT162b7 Bivalent (Original/OMI BA.4/BA.5) Biological
  • BNT162b7 Monovalent (OMI BA.4/BA.5) Biological

Biological

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 25, 2022
Primary completion
Mar 25, 2024
Completion
Mar 25, 2024
Last update posted
Sep 30, 2025

2022 – 2024

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801
California Research Foundation San Diego California 92123
Bayview Research Group, LLC Valley Village California 91607
Diablo Clinical Research, Inc. Walnut Creek California 94598
Clinical Research Consulting Milford Connecticut 06460
Research Centers of America ( Hollywood ) Hollywood Florida 33024
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256
Acevedo Clinical Research Associates Miami Florida 33142
Clinical Research Atlanta Stockbridge Georgia 30281
East-West Medical Research Institute Honolulu Hawaii 96814
Kentucky Pediatric/ Adult Research Bardstown Kentucky 40004
Clinical Research Professionals Chesterfield Missouri 63005
Sundance Clinical Research St Louis Missouri 63141
Velocity Clinical Research, Omaha Omaha Nebraska 68134
South Jersey Infectious Disease Somers Point New Jersey 08244
Rochester Clinical Research, LLC Rochester New York 14609
Accellacare - Charlotte Charlotte North Carolina 28211
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408
Accellacare - Wilmington Wilmington North Carolina 28401
Senders Pediatrics Cleveland Ohio 44121
Centricity Research Columbus Ohio Multispecialty Columbus Ohio 43213
Kaiser Permanente Northwest Center for Health Research Portland Oregon 97227
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
Benchmark Research Austin Texas 78705
Tekton Research, LLC. Austin Texas 78745
DM Clinical Research - Bellaire Houston Texas 77081
IMA Clinical Research San Antonio San Antonio Texas 78229
DM Clinical Research - MDC Tomball Texas 77375
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121
Virginia Research Center Midlothian Virginia 23114

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05472038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2025 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05472038 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →